ABSTRACT
Background: Patients with Coronavirus disease 2019 (COVID-19), caused by SARS-COV2 infection, can develop a potentially fatal rapid-onset pneumonia. In fact, mortality in patients hospitalized with COVID-19 can be as high as 20.3-27.9%.This study aimed to determine whether hyponatremia and hypernatremia are associated with a poor prognosis in patients admitted with COVID-19. Methods: Retrospective study conducted in Department of Respiratory Medicine, KIMS hospital and Research center, Bangalore , with a sample size of 1000 COVID 19 patients. Results: According to the above study, dysnatremia was found more in Category-C COVID19 patients, than cat A and Cat B, with 48.1% of patients in Cat C having dysnatremia, 29.9 % of Cat B and 24.3%of Cat C. In dysnatremia, hyponatremia was found was predominant among patients of Cat C COVID 19. Conclusion: Patients admitted with COVID 19, have risk of dysnatremia with increasing severity of the disease and it has significant impact on the morbidity and outcome of the patients.